Inverse Agonism at Serotonin and Cannabinoid Receptors
Vincent J. Aloyo, Kelly A. Berg, William P. Clarke, Umberto Spampinato, and John A. Harvey
2. G protein-coupled receptor heteromers as new targets for drug development
Sergi Ferre, Gemma Navarro, Vicent Casado, Antoni Cortes, Josefa Mallol, Enric I. Canela, Carme Lluis and Rafael Franco
3. Receptor activity modifying proteins and their potential as drug targets
Denise L. Wootten, John Simms, Debbie L. Hay, Arthur Christopoulos and Patrick M. Sexto
4. Regulators of G Protein Signaling Proteins As Targets For Drug Discovery
Benita Sjoegren, Levi L. Blazer and Richard R. Neubig
5. Escorts Take the Lead: Molecular Chaperones as Therapeutic Targets
Dumaine Williams and Lakshmi A. Dev
6. The T1r2/T1r3 Sweet Receptor and Trpm5 Ion Channel: Taste Targets With Therapeutic Potential
Dennis Sprous and R. Kyle Palmer
7. Membrane-associated enzymatic synthesis
Edward A. Esposito and Robert Weis
